Smart in OAC - AFNET 9

Smart in OAC - AFNET 9:

Multi-centre, multi-national, investigator-initiated, single-arm case-finding study of a cloud based analytic service as screening tool to detect and quantify episodes of atrial arrhythmia using an automated, wearable photoplethysmography-based monitoring system.

Further information

PATIENTS

Start of patient enrolment on 31 March, 2022. First patient-in on 31 January, 2021.

882 patients enrolled
4 sites open for recruitment

Status as of 31 May 2022. Updated are carried out quarterly

1000

Planned number of participants

PARTICIPATING COUNTRIES

Germany, Poland, Spain, UK

Chief Investigator

Prof. Dr. Larissa Fabritz, University of Birmingham

Sponsor

Atrial Fibrillation NETwork (AFNET), Münster, Germany

Registration

ClinicalTrials.gov: NCT04579159

Smart in OAC - AFNET 9